Snapshot of COVID-19 Related Clinical Trials in India
Authors
Jaykaran Charan
Department of Pharmacology, All India Institute of Medical Sciences, Jodhpur, India
Rimplejeet Kaur
Department of Pharmacology, S.N. Medical College, Jodhpur, India
Pankaj Bhardwaj
Department of Community and Family Medicine, All India Institute of Medical Sciences, Jodhpur, India
Tanuj Kanchan
Department of Forensic Medicine, All India Institute of Medical Sciences, Jodhpur, India
Prasenjit Mitra
Department of Biochemistry, All India Institute of Medical Sciences, Jodhpur, India
Dharmveer Yadav
Department of Biochemistry, All India Institute of Medical Sciences, Jodhpur, India
Praveen Sharma
Department of Biochemistry, All India Institute of Medical Sciences, Jodhpur, India
Sanjeev Misra
Department of Surgical Oncology, All India Institute of Medical Sciences, Jodhpur, India
Keywords:
COVID 19, Trials, AYUSH, Treatment, Prophylaxis
Abstract
Many interventions are being explored for the prophylaxis and treatment of COVID-19 in all over the world including India. There was a need of systematic data about the COVID-19 related clinical trials conducted in India. The aim of the present study was to analyze various clinical trials registered in Clinical Trial Registry of India (CTRI) exploring the interventions for COVID 19. The data of various clinical trials being conducted in India was obtained from CTRI. Different trial characteristics were extracted in the predesigned proforma and analyzed. Values were expressed in frequency and percentages. As of 11th July, 2020, a total of 203 trials were registered in the CTRI. The majority of the trials (61%) were related to the AYUSH interventions. Only 3 trials were international while the others were national. A major portion of public and private funding were dedicated to the AYUSH trials. More number of trials were for treatment as compared to prophylaxis. Maharashtra and Delhi are having highest number of trial sites. There is a good progress regarding AYUSH clinical trials, and a similar progress is expected for allopathic interventions.
Keywords: COVID 19, Trials, AYUSH, Treatment, Prophylaxis
Click on "Archives" to access the full archive of scientific preprints. You may use the categories and the search functionality to find select preprints you're interested in.